The Synthetic Biology Innovation Network

Editors' picks

Zymergen Announces $400 Million in Series C Funding led by the SoftBank Vision Fund

Institutional investors rally behind molecular technology’s blue-chip market opportunity EMERYVILLE, CA (Dec 13, 2018) – Zymergen, the world’s first molecular manufacturing technology company, announced today it...

The Ladder of Proof: How VCs see your startup

How to win in the bioeconomy: A peek at Rob Carlson’s playbook

The bioeconomy is booming, and most predict it will grow even more in the coming years. In a field that changes and learns new things daily, it can be hard to wrap our minds around not only the future of synthetic...

Watch Panel “Bio is not another app: Investing in what’s important” at SynBioBeta 2018

Winning iGEM team uses Opentrons to create a 3x faster chassis for genetic engineering

Top tips for building your biotech startup team

It is said that investors put their money behind people, not ideas. This is supported by the fact that human factors (an incompatible team, lack of persistence, and loss of focus) are identified as primary causes of...

Cell-free expression platforms enable new possibilities at iGEM and beyond

BetaSpace: The innovation ecosystem for our on- and off- planet future

In 1961, John F. Kennedy captivated the imagination of people across our planet by announcing his goal of putting a man on the moon within the decade. Eight years later we did just that, and in doing so produced a...

Space Lab 3.0: Imagining the future of science in space

Farming on Mars: A future for synthetic biology off Earth

View all posts

Press releases

Intrexon and AquaBounty Receive Regulatory Exemption in Development of Gene Edited Tilapia for More Sustainable Production

Assessment by Argentina’s National Advisory Commission on Agricultural Biotechnology Sets Regulatory Precedent GERMANTOWN, Md. and MAYNARD, Mass., Dec. 18, 2018 /PRNewswire/ — Intrexon Corporation (NASDAQ:...

Cathay Industrial Biotech Invests an Additional USD 500 Million to Expand its Production Capacity for New Bio-based Materials

Cathay Industrial Biotech takes a decisive step to expand its output of bio-based pentamethylene diamine and long-chain diacids. This will double Cathay’s production capacity of the respective products at the Wusu...

Synthetic biology start-up Colorifix raises $3m Series A round to scale its revolutionary textile dyeing solution

Norwich, UK: Colorifix, a company that has developed the first commercial biological dyeing process, has raised a Series A round of $3 million from impact and strategic investors with strong links to the fashion...

BiomX Enters Collaboration with Johnson & Johnson Innovation for Discovery of Microbiome-based Biomarkers for IBD

BiomX’s XMarker microbiome-based biomarker discovery platform to identify responders to a key Janssen IBD therapeutic Ness Ziona, Israel – Dec. 12, 2018 – BiomX Ltd., a microbiome company developing customized phage...

Computer Aided Biology Pioneer Synthace Secures $25.6 Million in Series B Funding

Funding will be used to further expand product capabilities and fuel company growth Industry-leader is bringing software abstraction and automation to biological R&D and manufacturing 12 December – LONDON...

Synlogic Expands Capabilities in Manufacturing with the Appointment of Head of Technical Operations and Establishment of In-house Production of Clinical Trial Material for its Synthetic BioticTM Medicines

– Good Manufacturing Process (GMP) infrastructure enables advancement of clinical programs through early and mid-phase studies – – Capabilities support production of both liquid and solid oral formulations – CAMBRIDGE...

KnipBio Touts Success in Comprehensive Rainbow Trout Feed Trial

(Lowell, MA) December 4, 2018. KnipBio Inc. announced today the successful completion of an extended series of trials studying the efficacy of its single cell protein ingredient KnipBio Meal (KBM) in the diet of...

Precision BioSciences and Durham STEM Students Lead Launch of First Genome Editing Experiment Into Space

CAPE CANAVERAL, FL, USA, December 6th, 2018 – Precision BioSciences today announced that the world’s first genome editing experiment in space has been launched aboard a SpaceX Dragon cargo spacecraft on a Falcon 9...

Amyris Celebrates Launch of New Zero Calorie, Naturally-Derived Sweetener

Company Announces Market-Leading Partners to Accelerate Commercialization in 2019 EMERYVILLE, Calif., Dec. 04, 2018 (GLOBE NEWSWIRE) — Amyris, Inc. (Nasdaq:AMRS), a leader in the development and production of...

CELLINK and Prellis Biologics Inc. sign partnership to commercialize high-resolution holographic bioprinting technology for micro-printing

The partners will utilize their IP, expertise, and know-how to offer the first system enabling ultra-high resolution bioprinting of microstructures such as vascular networks or capillaries. The technology is an...

Berkeley Lights Launches Plasma B Cell Antibody Discovery Workflow on the Beacon® Optofluidic Platform

New workflow enables customers to speed novel antibody discovery from months to just one day Emeryville, Calif. – December 5, 2018 — Berkeley Lights, Inc. (BLI), a leader in digital cell biology, announced today the...

Renmatix and Gevo Sign a Joint Development Agreement to Evaluate the Commercial Feasibility of Creating Cellulosic Hydrocarbons for Global Renewable Jet Fuel and Gasoline Markets

Will explore capabilities to produce renewable fuels and chemicals to meet expanding demand ENGLEWOOD, Colo., Dec. 06, 2018 (GLOBE NEWSWIRE) — Gevo, Inc. (NASDAQ: GEVO) and Renmatix, the leader in affordable...

The Synthetic Biology Innovation Network

Editors' picks

Press releases

News by topic